Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening (Q40299423)

19 September 2017

title

Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening (English)

1 reference

19 September 2017

13

1 reference

19 September 2017

Eduardo L Franco

7

0 references

François Coutlée

4

object named as

François Coutlée

1 reference

19 September 2017

6

Alex Ferenczy

1 reference

19 September 2017

10

Marie-Hélène Mayrand

1 reference

19 September 2017

14

Sam Ratnam

1 reference

19 September 2017

5

Máire A Duggan

1 reference

19 September 2017

Michael Fung-Kee-Fung

8

object named as

Michael Fung-Kee-Fung

1 reference

19 September 2017

9

Walter Gotlieb

1 reference

19 September 2017

11

Meg McLachlin

1 reference

19 September 2017

Joseph E Tota

1

1 reference

19 September 2017

James Bentley

2

1 reference

19 September 2017

Jennifer Blake

3

1 reference

19 September 2017

Joan Murphy

12

1 reference

19 September 2017

language of work or name

English

0 references

publication date

6 February 2017

1 reference

19 September 2017

1 reference

19 September 2017

volume

98

1 reference

19 September 2017

page(s)

15-20

1 reference

Performance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Human papillomavirus DNA methylation as a potential biomarker for cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Cost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Semantic focusing allows fully automated single-layer slide scanning of cervical cytology slides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Lower cost strategies for triage of human papillomavirus DNA-positive women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

A cohort study of cervical screening using partial HPV typing and cytology triage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Effectiveness of Cervical Cancer Screening at Different Ages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Triage of HPV positive women in cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

The ATHENA human papillomavirus study: design, methods, and baseline results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.11.030

10.1016/J.YPMED.2016.11.030

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference